Craig Lipset

See the following -

Chip Away At The Stone: REMOTE, Transparency Life Sciences

Lisa Henderson | Applied Clinical Trials | February 1, 2013

(This blog is part 2 of my interview with Tomasz Sablinski, MD, PhD, Founder and CEO of Transparency Life Sciences. As noted in my first blog, Sablinski’s company announced it was the first company to have an IND cleared using a crowdsourced protocol. [...] Read More »

More Research Volunteers Are Getting Their Medical Test Results. Should We Cheer — or Worry?

Kat McGowan | STAT | December 1, 2016

Volunteer for a clinical trial and your body will be poked, prodded, scanned, and analyzed. But you’re unlikely to get any of the results. A small but influential band of activists has been pushing hard to change that — and they’re starting to get traction. The research establishment has long opposed giving volunteers access to their data, even though that’s supposed to be part of the arrangement. Some worry that it’s too easy for laypeople to misinterpret test results, while others maintain that it’s a waste of resources to organize data for individual review...

Read More »

Trial Designed With Crowd Input Gets FDA Signoff

Marc Iskowitz | MM&M | December 28, 2012

What's been called the first clinical study protocol developed using crowdsourcing methods received the FDA's imprimatur earlier this month. The agency approved Transparency Life Sciences' IND for a clinical trial designed to test a generic blood-pressure medication, ACE inhibitor lisinopril, in patients with relapsing remitting multiple sclerosis. Read More »